SDGR

Schrodinger Inc

SDGR, USA

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

https://www.schrodinger.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
SDGR
stock
SDGR

Wall Street Analysts Believe Schrodinger (SDGR) Could Rally 46.17%: Here's is How to Trade Nasdaq

Read more →
SDGR
stock
SDGR

ARK Investment Acquires Additional Shares of Schrodinger (SDGR) GuruFocus

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

STRONG BUY

Target Price:

$27.2222

Analyst Picks

Strong Buy

6

Buy

0

Hold

2

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very High

4.13

Low 1

High 3

Return on Equity (ROE)

-

Very Low

-10.21 %

Low 5%

High 25%

Return on Assets (ROA)

-

Very Low

-5.02 %

Low 2%

High 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-114.80 %

Low 5%

High 15%

Debt to Equity

-

Very Low

1.03

Low 1

High 0.3

Investors

* Institutions hold a combined 112.85% of the total shares of Schrodinger Inc

1.

BlackRock Inc

(13.283%)

since

2025/06/30

2.

Gates Bill & Melinda Foundation

(9.4852%)

since

2025/06/30

3.

Vanguard Group Inc

(8.9893%)

since

2025/06/30

4.

Rubric Capital Management LP

(6.7929%)

since

2025/06/30

5.

Sumitomo Mitsui Trust Group Inc

(4.9588%)

since

2025/06/30

6.

UBS Asset Mgmt Americas Inc

(4.6399%)

since

2025/06/30

7.

iShares Core S&P Small-Cap ETF

(4.5171%)

since

2025/08/31

8.

Cadian Capital Management LP

(4.1382%)

since

2025/06/30

9.

Amova Asset Management Americas, Inc

(3.5208%)

since

2025/06/30

10.

Stephens Inv Mgmt Group LLC

(3.0722%)

since

2025/06/30

11.

State Street Corp

(2.9695%)

since

2025/06/30

12.

ARK Investment Management LLC

(2.6618%)

since

2025/06/30

13.

ARK Genomic Revolution

(2.6044%)

since

2025/06/30

14.

Vanguard Total Stock Mkt Idx Inv

(2.6016%)

since

2025/07/31

15.

ARK Genomic Revolution ETF

(2.6013%)

since

2025/08/28

16.

Stephens SMID Select Growth

(2.1048%)

since

2025/06/30

17.

Massachusetts Financial Services Company

(2.0305%)

since

2025/06/30

18.

Vanguard Small Cap Index

(2.0106%)

since

2025/07/31

19.

Lazard Asset Management LLC

(1.9281%)

since

2025/06/30

20.

Geode Capital Management, LLC

(1.8512%)

since

2025/06/30

21.

iShares Russell 2000 ETF

(1.8422%)

since

2025/08/31

22.

UBS Group AG

(1.8205%)

since

2025/06/30

23.

Amova ARK Disruptive Innovation A USD

(1.7333%)

since

2025/07/31

24.

Vanguard Explorer Inv

(1.6126%)

since

2025/06/30

25.

Morgan Stanley - Brokerage Accounts

(1.5655%)

since

2025/06/30

26.

Farallon Capital Management, L.L.C.

(1.5026%)

since

2025/06/30

27.

American Century Companies Inc

(1.4762%)

since

2025/06/30

28.

MFS New Discovery I

(1.4522%)

since

2025/07/31

29.

Lazard Global Robotics & Automation

(1.4057%)

since

2025/06/30

30.

Baillie Gifford & Co Limited.

(1.3391%)

since

2025/06/30

31.

UBS Lux Dgtl Hlth Eq Fd seeding P acc

(1.3307%)

since

2025/07/31

32.

Amova ARK Pstv Chg Innovt P JPY Acc

(1.2896%)

since

2025/07/31

33.

Vanguard Small Cap Growth Index Inv

(1.1388%)

since

2025/07/31

34.

American Century U.S. Small Cap Growth

(1.1373%)

since

2025/06/30

35.

American Century Small Cap Growth Inv

(1.1373%)

since

2025/06/30

36.

Two Sigma Investments LLC

(1.1156%)

since

2025/06/30

37.

Stephens Small Cap Growth

(0.9351%)

since

2025/06/30

38.

Vanguard Institutional Extnd Mkt Idx Tr

(0.8163%)

since

2025/07/31

39.

Fidelity Small Cap Index

(0.768%)

since

2025/06/30

40.

iShares Russell 2000 Growth ETF

(0.6738%)

since

2025/08/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

-0.22

Latest Release

Date

2025-09-30

EPS Actual

-0.45

EPS Estimate

-0.71

EPS Difference

0.26

Surprise Percent

36.6197%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Weak Deep Value(2.5)
Defensive
Moderately Defensive(6)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(4.3)
GARP
Not Attractive for GARP(1.5)
Growth
Weak Growth Prospect(1)
Momentum
Moderate Momentum(3.5)
Net Net
Not Undervalued (Net-Net)(2.5)
Quality
Low Quality Business(2)
Value
Overpriced(3)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.